{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T14:02:02Z","timestamp":1781013722258,"version":"3.54.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s11060-026-05610-7","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T12:57:26Z","timestamp":1779109046000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Outcome of CyberKnife stereotactic radiosurgery for the brain metastases in patients with Li Fraumeni syndrome"],"prefix":"10.1007","volume":"178","author":[{"given":"Muhammad","family":"Izhar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke S.","family":"Hori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahed H.","family":"Kattaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Harary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred C.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeraj","family":"Kalra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirmeen","family":"Zagzoog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armine","family":"Tayag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louisa","family":"Ustrzynski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara C.","family":"Emrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven D.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,18]]},"reference":[{"key":"5610_CR1","unstructured":"Schneider K, Zelley K, Nichols KE, Levine AS, Garber J (2025) Li-fraumeni syndrome. GeneReviews\u00ae[Internet]"},{"issue":"6","key":"5610_CR2","doi-asserted-by":"publisher","first-page":"NP5","DOI":"10.1177\/03008916241255485","volume":"110","author":"V Cognigni","year":"2024","unstructured":"Cognigni V, Capelletto E, Bordi P, Pavese V, Carf\u00ec FM, Gelsomino F et al (2024) A case series of non-small cell lung cancer patients with EGFR or HER2 exon 20 insertion in Li Fraumeni syndrome. Tumori J 110(6):NP5\u201310. https:\/\/doi.org\/10.1177\/03008916241255485","journal-title":"Tumori J"},{"issue":"1","key":"5610_CR3","first-page":"1","volume":"150","author":"P Kleihues","year":"1997","unstructured":"Kleihues P, Sch\u00e4uble B, zur Hausen A, Est\u00e8ve J, Ohgaki H (1997) Tumors associated with p53 germline mutations: a synopsis of 91 families. Am J Pathol 150(1):1\u201313 PubMed PMID: 9006316; PubMed Central PMCID: PMC1858532","journal-title":"Am J Pathol"},{"issue":"20","key":"5610_CR4","first-page":"6643","volume":"63","author":"M Olivier","year":"2003","unstructured":"Olivier M, Goldgar DE, Sodha N, Ohgaki H, Kleihues P, Hainaut P et al (2003) Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype. Cancer Res 63(20):6643\u20136650 PubMed PMID: 14583457","journal-title":"Cancer Res"},{"issue":"3","key":"5610_CR5","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/humu.10185","volume":"21","author":"JM Varley","year":"2003","unstructured":"Varley JM (2003) GermlineTP53 mutations and Li-Fraumeni syndrome. Hum Mutat 21(3):313\u2013320. https:\/\/doi.org\/10.1002\/humu.10185","journal-title":"Hum Mutat"},{"key":"5610_CR6","doi-asserted-by":"publisher","first-page":"100541","DOI":"10.1016\/j.wnsx.2025.100541","volume":"28","author":"M Izhar","year":"2025","unstructured":"Izhar M, Hori YS, Kattaa AH, Lam FC, Kalra N, Zagzoog N et al (2025) Stereotactic radiosurgery for hepatitis C virus-related hepatocellular carcinoma brain metastasis: A retrospective analysis and systematic review. World Neurosurg X 28:100541. https:\/\/doi.org\/10.1016\/j.wnsx.2025.100541","journal-title":"World Neurosurg X"},{"issue":"3","key":"5610_CR7","doi-asserted-by":"publisher","first-page":"444","DOI":"10.3171\/jns.1992.76.3.0444","volume":"76","author":"JR Adler","year":"1992","unstructured":"Adler JR, Cox RS, Kaplan I, Martin DP (1992) Stereotactic radiosurgical treatment of brain metastases. J Neurosurg 76(3):444\u2013449. https:\/\/doi.org\/10.3171\/jns.1992.76.3.0444","journal-title":"J Neurosurg"},{"issue":"1","key":"5610_CR8","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1093\/jnci\/87.1.34","volume":"87","author":"E Alexander","year":"1995","unstructured":"Alexander E, Moriarty TM, Davis RB, Wen PY, Fine HA, Black PM et al (1995) Stereotactic Radiosurgery for the Definitive, Noninvasive Treatment of Brain Metastases. JNCI J Natl Cancer Inst 87(1):34\u201340. https:\/\/doi.org\/10.1093\/jnci\/87.1.34","journal-title":"JNCI J Natl Cancer Inst"},{"issue":"4","key":"5610_CR9","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/0360-3016(94)00461-S","volume":"32","author":"JM Buatti","year":"1995","unstructured":"Buatti JM, Friedman WA, Bova FJ, Mendenhall WM (1995) Treatment selection factors for stereotactic radiosurgery of intracranial metastases. Int J Radiat Oncol 32(4):1161\u20131166. https:\/\/doi.org\/10.1016\/0360-3016(94)00461-S","journal-title":"Int J Radiat Oncol"},{"issue":"1","key":"5610_CR10","first-page":"81","volume":"8","author":"JC Flickinger","year":"1994","unstructured":"Flickinger JC, Loeffler JS, Larson DA (1994) Stereotactic radiosurgery for intracranial malignancies. Oncol Williston Park N 8(1):81\u201386 discussion 86, 94, 97\u20138. PubMed PMID: 8123451","journal-title":"Oncol Williston Park N"},{"issue":"1","key":"5610_CR11","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1159\/000100659","volume":"61","author":"L Kihlstr\u00f6m","year":"1993","unstructured":"Kihlstr\u00f6m L, Karlsson B, Lindquist C (1993) Gamma Knife Surgery for Cerebral Metastases. Implications for Survival Based on 16 Years Experience. Stereotact Funct Neurosurg 61(1):45\u201350. https:\/\/doi.org\/10.1159\/000100659","journal-title":"Stereotact Funct Neurosurg"},{"issue":"1","key":"5610_CR12","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1023\/A:1005958215384","volume":"37","author":"J Williams","year":"1998","unstructured":"Williams J, Enger C, Wharam M, Tsai D, Brem H (1998) Stereotactic radiosurgery for brain metastases: Comparison of lung carcinoma vs. non-lung tumors. J Neurooncol 37(1):79\u201385. https:\/\/doi.org\/10.1023\/A:1005958215384","journal-title":"J Neurooncol"},{"issue":"1","key":"5610_CR13","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s11060-025-05247-y","volume":"176","author":"AH Kattaa","year":"2026","unstructured":"Kattaa AH, Persad AR, Hori YS, Harary PM, Izhar M, Ustrzynski L et al (2026) Peripheral neural crest tumor brain metastases management: a single-institution retrospective study. J Neurooncol 176(1):65. https:\/\/doi.org\/10.1007\/s11060-025-05247-y","journal-title":"J Neurooncol"},{"key":"5610_CR14","doi-asserted-by":"publisher","first-page":"526","DOI":"10.25259\/SNI_806_2025","volume":"16","author":"M Izhar","year":"2025","unstructured":"Izhar M, Kattaa AH, Hori YS, Lam FC, Tayag A, Ustrzynski L et al (2025) Hepatoblastoma brain metastasis treated with stereotactic radiosurgery: Illustrative case and literature search. Surg Neurol Int 16:526. https:\/\/doi.org\/10.25259\/SNI_806_2025","journal-title":"Surg Neurol Int"},{"issue":"1","key":"5610_CR15","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1007\/s10143-025-03761-1","volume":"48","author":"AH Kattaa","year":"2025","unstructured":"Kattaa AH, Hori YS, Harary PM, Akhavan-Sigari A, Zamarud A, Persad AR et al (2025) Adenoid cystic carcinoma brain metastases treated with stereotactic radiosurgery: A single institution retrospective cohort study and comprehensive literature review. Neurosurg Rev 48(1):618. https:\/\/doi.org\/10.1007\/s10143-025-03761-1","journal-title":"Neurosurg Rev"},{"issue":"2","key":"5610_CR16","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s11060-026-05542-2","volume":"177","author":"M Izhar","year":"2026","unstructured":"Izhar M, Kattaa AH, Hori YS, Lam FC, Kalra N, Zagzoog N et al (2026) Treatment outcomes of stereotactic radiosurgery for sarcoma brain metastases\u2014systematic review. J Neurooncol 177(2):70. https:\/\/doi.org\/10.1007\/s11060-026-05542-2","journal-title":"J Neurooncol"},{"key":"5610_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.meddos.2018.02.006","author":"C Ding","year":"2018","unstructured":"Ding C, Saw CB, Timmerman RD (2018) Cyberknife stereotactic radiosurgery and radiation therapy treatment planning system. Plan Syst 43(2):129\u2013140. https:\/\/doi.org\/10.1016\/j.meddos.2018.02.006. Spec Issue 3D Treat"},{"issue":"3","key":"5610_CR18","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s10585-020-10031-5","volume":"37","author":"M Loo","year":"2020","unstructured":"Loo M, Pin Y, Thierry A, Clavier JB (2020) Single-fraction radiosurgery versus fractionated stereotactic radiotherapy in patients with brain metastases: a comparative study. Clin Exp Metastasis 37(3):425\u2013434. https:\/\/doi.org\/10.1007\/s10585-020-10031-5","journal-title":"Clin Exp Metastasis"},{"key":"5610_CR19","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ejca.2016.03.081","volume":"62","author":"LH Schwartz","year":"2016","unstructured":"Schwartz LH, Liti\u00e8re S, De Vries E, Ford R, Gwyther S, Mandrekar S et al (2016) RECIST 1.1\u2014Update and clarification: From the RECIST committee. Eur J Cancer 62:132\u2013137. https:\/\/doi.org\/10.1016\/j.ejca.2016.03.081","journal-title":"Eur J Cancer"},{"issue":"1","key":"5610_CR20","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/s41588-025-02446-1","volume":"58","author":"K Laue","year":"2026","unstructured":"Laue K, Pozzi S, Zerbib J, Bertolio R, Eliezer Y, Cohen-Sharir Y et al (2026) p53 inactivation drives breast cancer metastasis to the brain through SCD1 upregulation and increased fatty acid metabolism. Nat Genet 58(1):116\u2013131. https:\/\/doi.org\/10.1038\/s41588-025-02446-1","journal-title":"Nat Genet"},{"issue":"1","key":"5610_CR21","doi-asserted-by":"publisher","first-page":"e23199","DOI":"10.1002\/gcc.23199","volume":"63","author":"I Grote","year":"2024","unstructured":"Grote I, Poppe A, Lehmann U, Christgen M, Kreipe H, Bartels S (2024) Frequency of genetic alterations differs in advanced breast cancer between metastatic sites. Genes Chromosomes Cancer 63(1):e23199. https:\/\/doi.org\/10.1002\/gcc.23199","journal-title":"Genes Chromosomes Cancer"},{"issue":"5","key":"5610_CR22","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1016\/S0360-3016(02)02861-4","volume":"53","author":"RS Bubb","year":"2002","unstructured":"Bubb RS, Komaki R, Hachiya T, Milas I, Ro JY, Langford L et al (2002) Association of Ki-67, p53, and bcl-2 expression of the primary non-small-cell lung cancer lesion with brain metastatic lesion. Int J Radiat Oncol 53(5):1216\u20131224. https:\/\/doi.org\/10.1016\/S0360-3016(02)02861-4","journal-title":"Int J Radiat Oncol"},{"key":"5610_CR23","doi-asserted-by":"publisher","first-page":"105717","DOI":"10.1016\/j.humpath.2025.105717","volume":"155","author":"J Lasota","year":"2025","unstructured":"Lasota J, Kaczorowski M, Ch\u0142opek M, Mi\u0142ek-Krupa J, Szczepaniak M, Ylaya K et al (2025) An immunohistochemical and molecular genetic study of 60 colorectal carcinoma brain metastases in pursuit of predictive biomarkers for cancer therapy. Hum Pathol 155:105717. https:\/\/doi.org\/10.1016\/j.humpath.2025.105717","journal-title":"Hum Pathol"},{"issue":"11","key":"5610_CR24","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1038\/s41419-022-05408-1","volume":"13","author":"X Chen","year":"2022","unstructured":"Chen X, Zhang T, Su W, Dou Z, Zhao D, Jin X et al (2022) Mutant p53 in cancer: from molecular mechanism to therapeutic modulation. Cell Death Dis 13(11):974. https:\/\/doi.org\/10.1038\/s41419-022-05408-1","journal-title":"Cell Death Dis"},{"key":"5610_CR25","doi-asserted-by":"publisher","first-page":"100277","DOI":"10.1016\/j.jlb.2024.100277","volume":"6","author":"M Izhar","year":"2024","unstructured":"Izhar M, Thakur A, Park DJ, Chang SD (2024) Ultrasound mediated blood-brain barrier opening increases brain tumor biomarkers: A review of preclinical and clinical trials. J Liq Biopsy 6:100277. https:\/\/doi.org\/10.1016\/j.jlb.2024.100277","journal-title":"J Liq Biopsy"},{"key":"5610_CR26","doi-asserted-by":"publisher","first-page":"100170","DOI":"10.1016\/j.jlb.2024.100170","volume":"6","author":"M Izhar","year":"2024","unstructured":"Izhar M, Ahmad Z, Moazzam M, Jader A (2024) Targeted liquid biopsy for brain tumors. J Liq Biopsy 6:100170. https:\/\/doi.org\/10.1016\/j.jlb.2024.100170","journal-title":"J Liq Biopsy"},{"issue":"5","key":"5610_CR27","doi-asserted-by":"publisher","first-page":"e70051","DOI":"10.1002\/jex2.70051","volume":"4","author":"M Izhar","year":"2025","unstructured":"Izhar M, Lesniak MS (2025) Role of Extracellular Vesicles in the Pathogenesis of Brain Metastasis. J Extracell Biol 4(5):e70051. https:\/\/doi.org\/10.1002\/jex2.70051","journal-title":"J Extracell Biol"},{"key":"5610_CR28","doi-asserted-by":"publisher","first-page":"1470560","DOI":"10.3389\/fonc.2024.1470560","volume":"14","author":"IK Sumou","year":"2024","unstructured":"Sumou IK, Hui CV (2024) Case report: Efficacy of later-line fam-trastuzumab deruxtecan in a patient with triple-positive breast cancer with brain metastases. Front Oncol 14:1470560. https:\/\/doi.org\/10.3389\/fonc.2024.1470560","journal-title":"Front Oncol"},{"issue":"2","key":"5610_CR29","first-page":"91","volume":"9","author":"JX Leng","year":"2024","unstructured":"Leng JX, Su C, Carpenter DJ, Floyd W, Vaios E, Shenker R et al (2024) Impact of TP53 mutations on brain metastasis control in non-small cell lung cancer patients undergoing stereotactic radiosurgery. J Radiosurgery SBRT 9(2):91\u201399 PubMed PMID: 39087065; PubMed Central PMCID: PMC11288656","journal-title":"J Radiosurgery SBRT"},{"issue":"2","key":"5610_CR30","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3857\/roj.2018.00290","volume":"36","author":"CB Dracham","year":"2018","unstructured":"Dracham CB, Shankar A, Madan R (2018) Radiation induced secondary malignancies: a review article. Radiat Oncol J 36(2):85\u201394. https:\/\/doi.org\/10.3857\/roj.2018.00290","journal-title":"Radiat Oncol J"},{"issue":"4","key":"5610_CR31","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/S1470-2045(11)70061-4","volume":"12","author":"AB De Gonzalez","year":"2011","unstructured":"De Gonzalez AB, Curtis RE, Kry SF, Gilbert E, Lamart S, Berg CD et al (2011) Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries. Lancet Oncol 12(4):353\u2013360. https:\/\/doi.org\/10.1016\/S1470-2045(11)70061-4","journal-title":"Lancet Oncol"},{"issue":"12","key":"5610_CR32","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1007\/s10147-021-02011-w","volume":"26","author":"T Kumamoto","year":"2021","unstructured":"Kumamoto T, Yamazaki F, Nakano Y, Tamura C, Tashiro S, Hattori H et al (2021) Medical guidelines for Li\u2013Fraumeni syndrome 2019, version 1.1. Int J Clin Oncol 26(12):2161\u20132178. https:\/\/doi.org\/10.1007\/s10147-021-02011-w","journal-title":"Int J Clin Oncol"},{"issue":"1","key":"5610_CR33","doi-asserted-by":"publisher","first-page":"a003210","DOI":"10.1101\/mcs.a003210","volume":"5","author":"M Swaminathan","year":"2019","unstructured":"Swaminathan M, Bannon SA, Routbort M, Naqvi K, Kadia TM, Takahashi K et al (2019) Hematologic malignancies and Li\u2013Fraumeni syndrome. Mol Case Stud 5(1):a003210. https:\/\/doi.org\/10.1101\/mcs.a003210","journal-title":"Mol Case Stud"},{"issue":"1","key":"5610_CR34","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s10689-019-00153-5","volume":"19","author":"V Petry","year":"2020","unstructured":"Petry V, Bonadio RC, Cagnacci AQC, Senna LAL, Campos RDNG, Cotti GC et al (2020) Radiotherapy-induced malignancies in breast cancer patients with TP53 pathogenic germline variants (Li\u2013Fraumeni syndrome). Fam Cancer 19(1):47\u201353. https:\/\/doi.org\/10.1007\/s10689-019-00153-5","journal-title":"Fam Cancer"},{"issue":"1","key":"5610_CR35","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/1748-717X-5-104","volume":"5","author":"S Heymann","year":"2010","unstructured":"Heymann S, Delaloge S, Rahal A, Caron O, Frebourg T, Barreau L et al (2010) Radio-induced malignancies after breast cancer postoperative radiotherapy in patients with Li-Fraumeni syndrome. Radiat Oncol 5(1):104. https:\/\/doi.org\/10.1186\/1748-717X-5-104","journal-title":"Radiat Oncol"},{"issue":"1","key":"5610_CR36","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s10549-020-05612-7","volume":"181","author":"AN Le","year":"2020","unstructured":"Le AN, Harton J, Desai H, Powers J, Zelley K, Bradbury AR et al (2020) Frequency of radiation-induced malignancies post-adjuvant radiotherapy for breast cancer in patients with Li-Fraumeni syndrome. Breast Cancer Res Treat 181(1):181\u2013188. https:\/\/doi.org\/10.1007\/s10549-020-05612-7","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"5610_CR37","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.ijrobp.2024.01.204","volume":"119","author":"V Petry","year":"2024","unstructured":"Petry V, Bonadio RC, Moutinho K, Leite LS, Testa L, Cohn DJBH et al (2024) Frequency of Radiation Therapy-Induced Malignancies in Patients With Li-Fraumeni Syndrome and Early-Stage Breast Cancer and the Influence of Radiation Therapy Technique. Int J Radiat Oncol 119(4):1086\u20131091. https:\/\/doi.org\/10.1016\/j.ijrobp.2024.01.204","journal-title":"Int J Radiat Oncol"},{"issue":"4Supplement","key":"5610_CR38","first-page":"PS1","volume":"32","author":"AA Shrebati","year":"2026","unstructured":"Shrebati AA, Loap P, Mouret-Fourme E, Cao K, Belotti M, Stoppa-Lyonnet D et al (2026) Abstract PS1-03-06: Radiation therapy for breast cancer in patients with Li-Fraumeni syndrome (LFS): a single institution cohort study. Clin Cancer Res 32(4Supplement):PS1. 03-06-PS1-03-6","journal-title":"Clin Cancer Res"},{"issue":"1","key":"5610_CR39","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1667\/RR3190","volume":"162","author":"REJ Mitchel","year":"2004","unstructured":"Mitchel REJ, Jackson JS, Carlisle SM (2004) Upper Dose Thresholds for Radiation-Induced Adaptive Response against Cancer in High-Dose-Exposed, Cancer-Prone, Radiation-Sensitive Trp53 Heterozygous Mice. Radiat Res 162(1):20\u201330. https:\/\/doi.org\/10.1667\/RR3190","journal-title":"Radiat Res"},{"issue":"1","key":"5610_CR40","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/ng0994-66","volume":"8","author":"CJ Kemp","year":"1994","unstructured":"Kemp CJ, Wheldon T, Balmain A (1994) p53-deficient mice are extremely susceptible to radiation-induced tumorigenesis. Nat Genet 8(1):66\u201369. https:\/\/doi.org\/10.1038\/ng0994-66","journal-title":"Nat Genet"},{"issue":"21","key":"5610_CR41","doi-asserted-by":"publisher","first-page":"7954","DOI":"10.1002\/cam4.3427","volume":"9","author":"PG Hendrickson","year":"2020","unstructured":"Hendrickson PG, Luo Y, Kohlmann W, Schiffman J, Maese L, Bishop AJ et al (2020) Radiation therapy and secondary malignancy in Li-Fraumeni syndrome: A hereditary cancer registry study. Cancer Med 9(21):7954\u20137963. https:\/\/doi.org\/10.1002\/cam4.3427","journal-title":"Cancer Med"},{"issue":"6","key":"5610_CR42","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S0305-7372(03)00105-1","volume":"29","author":"RA Patchell","year":"2003","unstructured":"Patchell RA (2003) The management of brain metastases. Cancer Treat Rev 29(6):533\u2013540. https:\/\/doi.org\/10.1016\/S0305-7372(03)00105-1","journal-title":"Cancer Treat Rev"},{"issue":"2","key":"5610_CR43","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/S0360-3016(99)00198-4","volume":"45","author":"D Kondziolka","year":"1999","unstructured":"Kondziolka D, Patel A, Lunsford LD, Kassam A, Flickinger JC (1999) Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol 45(2):427\u2013434. https:\/\/doi.org\/10.1016\/S0360-3016(99)00198-4","journal-title":"Int J Radiat Oncol"},{"issue":"21","key":"5610_CR44","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1001\/jama.295.21.2483","volume":"295","author":"H Aoyama","year":"2006","unstructured":"Aoyama H, Shirato H, Tago M, Nakagawa K, Toyoda T, Hatano K et al (2006) Stereotactic Radiosurgery Plus Whole-Brain Radiation Therapy vs Stereotactic Radiosurgery Alone for Treatment of Brain Metastases: A Randomized Controlled Trial. JAMA 295(21):2483. https:\/\/doi.org\/10.1001\/jama.295.21.2483","journal-title":"JAMA"},{"issue":"12","key":"5610_CR45","doi-asserted-by":"publisher","first-page":"e562","DOI":"10.1016\/S1470-2045(21)00425-3","volume":"22","author":"J Thariat","year":"2021","unstructured":"Thariat J, Chevalier F, Orbach D, Ollivier L, Marcy PY, Corradini N et al (2021) Avoidance or adaptation of radiotherapy in patients with cancer with Li-Fraumeni and heritable TP53-related cancer syndromes. Lancet Oncol 22(12):e562\u2013e574. https:\/\/doi.org\/10.1016\/S1470-2045(21)00425-3","journal-title":"Lancet Oncol"},{"issue":"1","key":"5610_CR46","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41467-022-35727-y","volume":"14","author":"N Light","year":"2023","unstructured":"Light N, Layeghifard M, Attery A, Subasri V, Zatzman M, Anderson ND et al (2023) Germline TP53 mutations undergo copy number gain years prior to tumor diagnosis. Nat Commun 14(1):77. https:\/\/doi.org\/10.1038\/s41467-022-35727-y","journal-title":"Nat Commun"},{"key":"5610_CR47","doi-asserted-by":"publisher","first-page":"662943","DOI":"10.3389\/fonc.2021.662943","volume":"11","author":"S Gupta","year":"2021","unstructured":"Gupta S, Dawood H, Giantini Larsen A, Fandino L, Knelson EH, Smith TR et al (2021) Surgical and Peri-Operative Considerations for Brain Metastases. Front Oncol 11:662943. https:\/\/doi.org\/10.3389\/fonc.2021.662943","journal-title":"Front Oncol"},{"key":"5610_CR48","doi-asserted-by":"publisher","first-page":"847110","DOI":"10.3389\/fonc.2022.847110","volume":"12","author":"CI Ene","year":"2022","unstructured":"Ene CI, Ferguson SD (2022) Surgical Management of Brain Metastasis: Challenges and Nuances. Front Oncol 12:847110. https:\/\/doi.org\/10.3389\/fonc.2022.847110","journal-title":"Front Oncol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05610-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-026-05610-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05610-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T13:40:15Z","timestamp":1781012415000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-026-05610-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["5610"],"URL":"https:\/\/doi.org\/10.1007\/s11060-026-05610-7","relation":{"references":[{"id-type":"doi","id":"10.1016\/j.meddos.2018.02.006","asserted-by":"subject"}],"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-9295398\/v1","asserted-by":"object"}]},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"1 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted with prior approval from the Stanford University Institutional Review Board (no. 3910) panel on Medical Human Subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4"}}